Zhitong Finance App News, Changchun Hi-Tech (000661.SZ) announced that the holding subsidiary of the company, Changchun Jinsai Pharmaceutical Co., Ltd. (“Jinsai Pharmaceutical”), received the “Notice of Acceptance” approved and issued by the State Drug Administration, and Jinsai Pharmaceutical's domestically produced drug registration application for injectable GenSci136 was accepted. The application indications are: for immunoglobulin A nephropathy (IgAN).

Zhitongcaijing · 4d ago
Zhitong Finance App News, Changchun Hi-Tech (000661.SZ) announced that the holding subsidiary of the company, Changchun Jinsai Pharmaceutical Co., Ltd. (“Jinsai Pharmaceutical”), received the “Notice of Acceptance” approved and issued by the State Drug Administration, and Jinsai Pharmaceutical's domestically produced drug registration application for injectable GenSci136 was accepted. The application indications are: for immunoglobulin A nephropathy (IgAN).